The mRNA level of FTH1 was decreased in the plasma of osteoporosis patients.<h4>Conclusions</h4>Downregulation of CRYAB boosted FTH1 degradation and increased cellular Fe and ROS levels, and finally improved the ferroptosis and lessened the osteogenic differentiation of BMSCs. This evidence concerns the gene FTH1 and osteoporosis.